Answer
Simponi (golimumab) with methotrexate is indicated for adults with moderate to severe active rheumatoid arthritis inadequately responsive to disease-modifying antirheumatic drug therapy including methotrexate, or severe, active and progressive rheumatoid arthritis not previously treated with methotrexate.
Sources for this answer
- Simponi 50 mg solution for injection in pre filled syringeJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.1 Therapeutic Indications · Version 41Document updated
Sources checked